193 related articles for article (PubMed ID: 2834250)
41. The effect of an aldose reductase inhibitor (Sorbinil) on the level of metabolites in lenses of diabetic rats.
Gonzalez AM; Sochor M; McLean P
Diabetes; 1983 May; 32(5):482-5. PubMed ID: 6404681
[TBL] [Abstract][Full Text] [Related]
42. Amelioration of glomerular hyperfiltration in acute experimental diabetes mellitus by dietary myo-inositol supplementation and aldose reductase inhibition.
Goldfarb S; Simmons DA; Kern EF
Trans Assoc Am Physicians; 1986; 99():67-72. PubMed ID: 3111062
[No Abstract] [Full Text] [Related]
43. Treatment with aldose reductase inhibitor or with myo-inositol arrests deterioration of the electroretinogram of diabetic rats.
MacGregor LC; Matschinsky FM
J Clin Invest; 1985 Aug; 76(2):887-9. PubMed ID: 3928685
[TBL] [Abstract][Full Text] [Related]
44. The effects of sorbinil on peripheral nerve conduction velocity, polyol concentrations and morphology in the streptozotocin-diabetic rat.
Cameron NE; Leonard MB; Ross IS; Whiting PH
Diabetologia; 1986 Mar; 29(3):168-74. PubMed ID: 3084324
[TBL] [Abstract][Full Text] [Related]
45. Reversal of diabetic cataract by sorbinil, an aldose reductase inhibitor.
Beyer-Mears A; Cruz E
Diabetes; 1985 Jan; 34(1):15-21. PubMed ID: 3917257
[TBL] [Abstract][Full Text] [Related]
46. Nonosmotic diabetic cataracts.
Malone JI; Lowitt S; Cook WR
Pediatr Res; 1990 Mar; 27(3):293-6. PubMed ID: 2138728
[TBL] [Abstract][Full Text] [Related]
47. Effect of increased glucose levels on Na+/K+-pump activity in cultured neuroblastoma cells.
Yorek MA; Dunlap JA; Ginsberg BH
J Neurochem; 1988 Aug; 51(2):605-10. PubMed ID: 2839622
[TBL] [Abstract][Full Text] [Related]
48. Comparison of the effects of Zopolrestat and Sorbinil on lens myo-inositol influx.
Beyer-Mears A; Diecke FP; Mistry K; Cruz E
Pharmacology; 1997 Feb; 54(2):76-83. PubMed ID: 9088040
[TBL] [Abstract][Full Text] [Related]
49. Evaluation of the effect of aldose reductase inhibition on increased basement membrane collagen fluorescence in diabetic rats.
Cohen MP; Klepser H; Wu VY
Gen Pharmacol; 1991; 22(4):603-6. PubMed ID: 1936894
[TBL] [Abstract][Full Text] [Related]
50. Undersulfation of glomerular basement membrane heparan sulfate in experimental diabetes and lack of correction with aldose reductase inhibition.
Cohen MP; Klepser H; Wu VY
Diabetes; 1988 Oct; 37(10):1324-7. PubMed ID: 2970980
[TBL] [Abstract][Full Text] [Related]
51. The effect of aldose reductase inhibition on motor nerve conduction velocity in diabetic rats.
Yue DK; Hanwell MA; Satchell PM; Turtle JR
Diabetes; 1982 Sep; 31(9):789-94. PubMed ID: 6819173
[TBL] [Abstract][Full Text] [Related]
52. Prevention of hemodynamic and vascular albumin filtration changes in diabetic rats by aldose reductase inhibitors.
Tilton RG; Chang K; Pugliese G; Eades DM; Province MA; Sherman WR; Kilo C; Williamson JR
Diabetes; 1989 Oct; 38(10):1258-70. PubMed ID: 2507378
[TBL] [Abstract][Full Text] [Related]
53. Prevention and reversal of defective axonal transport and motor nerve conduction velocity in rats with experimental diabetes by treatment with the aldose reductase inhibitor Sorbinil.
Tomlinson DR; Moriarty RJ; Mayer JH
Diabetes; 1984 May; 33(5):470-6. PubMed ID: 6202576
[TBL] [Abstract][Full Text] [Related]
54. Administration of an aldose reductase inhibitor induces a decrease of collagen fluorescence in diabetic rats.
Suárez G; Rajaram R; Bhuyan KC; Oronsky AL; Goidl JA
J Clin Invest; 1988 Aug; 82(2):624-7. PubMed ID: 3136193
[TBL] [Abstract][Full Text] [Related]
55. Normalization of Na(+)-K(+)-ATPase activity in isolated membrane fraction from sciatic nerves of streptozocin-induced diabetic rats by dietary myo-inositol supplementation in vivo or protein kinase C agonists in vitro.
Kim J; Kyriazi H; Greene DA
Diabetes; 1991 May; 40(5):558-67. PubMed ID: 1850704
[TBL] [Abstract][Full Text] [Related]
56. myo-Inositol and sorbitol in erythrocytes from diabetic patients before and after sorbinil treatment.
Popp-Snijders C; Lomecky-Janousek MZ; Schouten JA; van der Veen EA
Diabetologia; 1984 Nov; 27(5):514-6. PubMed ID: 6439588
[TBL] [Abstract][Full Text] [Related]
57. Prefeeding of aldose reductase inhibitor and galactose cataractogenesis.
Unakar NJ; Tsui JY; Johnson MJ
Curr Eye Res; 1989 Oct; 8(10):997-1010. PubMed ID: 2558845
[TBL] [Abstract][Full Text] [Related]
58. The effects of streptozotocin-induced diabetes and aldose reductase inhibition with sorbinil, on left and right atrial function in the rat.
Sellers DJ; Chess-Williams R
J Pharm Pharmacol; 2000 Jun; 52(6):687-94. PubMed ID: 10875546
[TBL] [Abstract][Full Text] [Related]
59. Effects of the aldose reductase inhibitor sorbinil on the isolated cultured rat lens.
Yeh LA; Rafford CE; Beyer TA; Hutson NJ
Metabolism; 1986 Apr; 35(4 Suppl 1):4-9. PubMed ID: 3083208
[TBL] [Abstract][Full Text] [Related]
60. Inhibition of galactose-induced alterations in ocular lens with sorbinil.
Unakar NJ; Tsui JY
Exp Eye Res; 1983 May; 36(5):685-94. PubMed ID: 6303825
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
